Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of the Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection

NCT04350086 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT04350086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04350086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of the Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection
Lead sponsor
University Hospital, Limoges
Phase
Phase 4
Overall status
Withdrawn
Start date
April 20, 2020
Completion date
November 20, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, palliative situation, respiratory failure, sars-cov-2